Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Pulmonology

Biology, Genetics & Diagnostic Criteria

At a Glance

Pulmonary fibrosis-hepatic hyperplasia-bone marrow hypoplasia syndrome is evaluated as a telomere biology disorder. Doctors combine Flow-FISH telomere length, genetic testing, family history, symptoms, and blood, liver, or marrow findings because no single test confirms or excludes it.

Understanding the biology of pulmonary fibrosis-hepatic hyperplasia-bone marrow hypoplasia syndrome requires looking deep inside your cells at structures called telomeres. While the name of the syndrome describes how your organs are affected, the “why” lies in your DNA [1][2].

What Are Telomeres?

Every cell in your body contains DNA, which is organized into structures called chromosomes. At the very tips of these chromosomes are telomeres—protective caps that prevent your genetic code from fraying or sticking to other chromosomes [3][4].

Each time a cell divides to repair tissue or create new cells, the telomeres get slightly shorter. Eventually, they become so short that the cell can no longer divide safely. At this point, the cell enters senescence (a state where it stops growing) or it dies [5][6]. In a Telomere Biology Disorder (TBD), this shortening happens much faster than normal, leading to “stem cell exhaustion” where your body can no longer replace damaged cells in the lungs, liver, or bone marrow [7][8].

The Genetics of Short Telomeres

Many adult-onset cases of this syndrome are caused by germline mutations in genes that provide instructions for maintaining telomeres.

  • Key Genes: Common genes involved include TERT and TERC, which are core components that help produce the enzyme telomerase [3][2]. Other genes, such as RTEL1, act differently by providing DNA-helicase proteins necessary for telomere replication and stability [1].
  • Inheritance: While many adult-onset TBDs show autosomal dominant inheritance (meaning you only need to inherit one copy to be at risk), these disorders can also be autosomal-recessive, X-linked, or the result of a de novo (new) mutation [9]. Penetrance can vary, meaning some relatives may carry the variant but remain unaffected [10].
  • Genetic Anticipation: In some families with specific variants, symptoms may appear earlier or be more severe in each passing generation, though this pattern is not guaranteed for everyone [9].

Diagnosis Checklist

Because this condition can mimic other diseases, doctors use a combination of tests to support a clinical diagnosis.

1. Flow-FISH Telomere Testing

This specialized blood test uses a technique called Flow-FISH to measure the exact length of telomeres in different types of white blood cells [11][12].

  • A result below the 1st percentile is strongly supportive of a TBD, but it is not an absolute diagnostic cutoff by itself [2][13].
  • Results between the 1st and 10th percentile are common in TBDs but can also occur in other conditions. Conversely, a normal result does not entirely exclude a TBD [11][14]. Diagnosis always combines this test with your clinical phenotype and genetics.

2. Comprehensive Genetic Panel

A blood test is used to sequence your DNA and look for mutations in known telomere-related genes [15]. It is important to know that in about 20-30% of cases, current genetic tests cannot find the specific mutation, even if the telomeres are very short [2]. Finding a “Variant of Uncertain Significance” (VUS) does not automatically establish the diagnosis [16].

3. Pathology and Laboratory Clues

Your care team will look for specific clues in your tissues, ruling out other reversible causes:

  • Macrocytosis: On a standard blood count (CBC), you may see a high MCV (mean corpuscular volume) [17]. This means your red blood cells are unusually large, which is a common clue of marrow stress, but doctors must also check for causes like B12 deficiency or alcohol use [18].
  • Nodular Regenerative Hyperplasia (NRH): In the liver, the body may create small “nodules” or bumps of new growth [19]. This is not true cirrhosis, but it can still cause high pressure in the liver’s blood vessels (portal hypertension) [20][21].
  • Hypocellular Marrow: A bone marrow biopsy may show that the marrow is hypocellular, meaning it has fewer blood-producing cells than expected for your age [22][23].

By combining your clinical symptoms, family history, telomere length, and genetic data, specialists can confirm the diagnosis and distinguish it from more common types of lung or liver disease.

Common questions in this guide

What does a very short telomere result mean?
Flow-FISH measures telomere length in different types of blood cells. A result below the first percentile strongly supports a telomere biology disorder, but no single result confirms the diagnosis; doctors also consider clinical findings, family history, and genetic results.
Which genes are checked for this telomere disorder?
Genetic panels may include TERT, TERC, RTEL1, and other genes involved in telomere maintenance. A panel may not find a mutation even when telomeres are very short, and a variant of uncertain significance does not by itself establish the diagnosis.
How is pulmonary fibrosis-hepatic hyperplasia-bone marrow hypoplasia syndrome diagnosed?
Doctors combine telomere-length testing, genetic testing, family history, physical findings, and blood, liver, or bone marrow results. They also rule out other explanations, such as vitamin B12 deficiency or alcohol use, that can cause some of the same laboratory findings.
What does macrocytosis or a high MCV mean in this condition?
Macrocytosis means that red blood cells are larger than usual, which can be a clue to bone marrow stress in a telomere biology disorder. Doctors still check for other causes, including vitamin B12 deficiency and alcohol use, before attributing the finding to telomere disease.
What does nodular regenerative hyperplasia mean on a liver biopsy?
Nodular regenerative hyperplasia means the liver has developed small areas of regenerative growth. It is not the same as cirrhosis, but it can increase pressure in the liver's blood vessels, a problem called portal hypertension.
Can telomere biology disorders run in families?
Yes. They may follow autosomal dominant, autosomal recessive, or X-linked inheritance, and some cases result from a new genetic change. Because relatives may carry a variant without obvious symptoms, a genetic counselor can help discuss testing and family implications.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Pulmonary fibrosis-hepatic hyperplasia-bone marrow hypoplasia syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was my telomere length measured using the Flow-FISH method, and what were the exact percentile results for my age?
  2. 2.Which specific genes were included in my genetic panel (e.g., TERT, TERC, RTEL1), and were any variants of uncertain significance (VUS) found?
  3. 3.Does my liver biopsy specifically show 'nodular regenerative hyperplasia' (NRH) or other vascular changes like 'porto-sinusoidal vascular disease'?
  4. 4.Is my 'macrocytosis' (large red blood cells) likely related to my telomeres, or are we checking for other causes like B12 deficiency?
  5. 5.Should I meet with a genetic counselor to discuss testing for my relatives?

References

References (23)
  1. 1

    Molecular mechanisms of telomere biology disorders.

    Grill S, Nandakumar J

    The Journal of biological chemistry 2021; (296()):100064 doi:10.1074/jbc.REV120.014017.

    PMID: 33482595
  2. 2

    Clinical manifestations of telomere biology disorders in adults.

    Niewisch MR, Beier F, Savage SA

    Hematology. American Society of Hematology. Education Program 2023; (2023(1)):563-572 doi:10.1182/hematology.2023000490.

    PMID: 38066848
  3. 3

    Telomere biology disorders: time for moving towards the clinic?

    Batista LFZ, Dokal I, Parker R

    Trends in molecular medicine 2022; (28(10)):882-891 doi:10.1016/j.molmed.2022.08.001.

    PMID: 36057525
  4. 4

    Shaping human telomeres: from shelterin and CST complexes to telomeric chromatin organization.

    Lim CJ, Cech TR

    Nature reviews. Molecular cell biology 2021; (22(4)):283-298 doi:10.1038/s41580-021-00328-y.

    PMID: 33564154
  5. 5

    ATM-dependent DNA damage response constrains cell growth and drives clonal hematopoiesis in telomere biology disorders.

    Sande CM, Chen S, Mitchell DV, et al.

    The Journal of clinical investigation 2025; (135(8)).

    PMID: 40179146
  6. 6

    Comparison of telomere length measurement methods.

    Lai TP, Wright WE, Shay JW

    Philosophical transactions of the Royal Society of London. Series B, Biological sciences 2018; (373(1741)) doi:10.1098/rstb.2016.0451.

    PMID: 29335378
  7. 7

    Recent advances in understanding telomere diseases.

    Carvalho VS, Gomes WR, Calado RT

    Faculty reviews 2022; (11()):31 doi:10.12703/r/11-31.

    PMID: 36311538
  8. 8

    Hematopoiesis under telomere attrition at the single-cell resolution.

    Thongon N, Ma F, Santoni A, et al.

    Nature communications 2021; (12(1)):6850 doi:10.1038/s41467-021-27206-7.

    PMID: 34824242
  9. 9

    Dyskeratosis congenita and telomere biology disorders.

    Savage SA

    Hematology. American Society of Hematology. Education Program 2022; (2022(1)):637-648 doi:10.1182/hematology.2022000394.

    PMID: 36485133
  10. 10

    A Proposed Clinical Diagnostic Framework for Short Telomere Syndrome.

    Courtwright A, King RA, Vagher J, et al.

    Clinical genetics 2026; (110(2)):139-149 doi:10.1111/cge.70190.

    PMID: 42219160
  11. 11

    Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified Criteria.

    Tometten M, Kirschner M, Meyer R, et al.

    HemaSphere 2023; (7(5)):e874 doi:10.1097/HS9.0000000000000874.

    PMID: 37096215
  12. 12

    The diagnostic performance of the basic versus the detailed telomere Flow FISH test in young patients with aplastic anaemia.

    DeCleene NF, Nguyen DT, Kirk SE, et al.

    British journal of haematology 2026; (208(3)):1093-1104 doi:10.1111/bjh.70155.

    PMID: 40988089
  13. 13

    Implementation of a prospective screening strategy to identify adults with a telomere biology disorder among those undergoing lung transplant evaluation for interstitial lung disease.

    Banaszak LG, Smith-Simmer K, Shoger K, et al.

    Respiratory medicine 2023; (220()):107464 doi:10.1016/j.rmed.2023.107464.

    PMID: 37951311
  14. 14

    Diagnostic utility of telomere length testing in a hospital-based setting.

    Alder JK, Hanumanthu VS, Strong MA, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2018; (115(10)):E2358-E2365 doi:10.1073/pnas.1720427115.

    PMID: 29463756
  15. 15

    The evolving genetic landscape of telomere biology disorder dyskeratosis congenita.

    Tummala H, Walne AJ, Badat M, et al.

    EMBO molecular medicine 2024; (16(10)):2560-2582.

    PMID: 39198715
  16. 16

    Optical Genomic Mapping and Next-Generation Sequencing Identified Retrotransposon Insertion and Missense Variant Disrupting PARN Gene in Dyskeratosis Congenita.

    Cao Q, Zhao A, Long Z, et al.

    Human mutation 2025; (2025()):9290736 doi:10.1155/humu/9290736.

    PMID: 40896794
  17. 17

    Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis.

    Borie R, Tabèze L, Thabut G, et al.

    The European respiratory journal 2016; (48(6)):1721-1731 doi:10.1183/13993003.02115-2015.

    PMID: 27836952
  18. 18

    Cancer spectrum and outcomes in the Mendelian short telomere syndromes.

    Schratz KE, Haley L, Danoff SK, et al.

    Blood 2020; (135(22)):1946-1956 doi:10.1182/blood.2019003264.

    PMID: 32076714
  19. 19

    Progression of liver disease and portal hypertension in dyskeratosis congenita and related telomere biology disorders.

    Vittal A, Niewisch MR, Bhala S, et al.

    Hepatology (Baltimore, Md.) 2023; (78(6)):1777-1787 doi:10.1097/HEP.0000000000000461.

    PMID: 37184208
  20. 20

    Hepatic manifestations of telomere biology disorders.

    Patnaik MM, Kamath PS, Simonetto DA

    Journal of hepatology 2018; (69(3)):736-743 doi:10.1016/j.jhep.2018.05.006.

    PMID: 29758336
  21. 21

    The Spectrum of Hepatic Involvement in Patients With Telomere Disease.

    Kapuria D, Ben-Yakov G, Ortolano R, et al.

    Hepatology (Baltimore, Md.) 2019; (69(6)):2579-2585 doi:10.1002/hep.30578.

    PMID: 30791107
  22. 22

    The clinical and functional effects of TERT variants in myelodysplastic syndrome.

    Reilly CR, Myllymäki M, Redd R, et al.

    Blood 2021; (138(10)):898-911 doi:10.1182/blood.2021011075.

    PMID: 34019641
  23. 23

    Challenges in the interpretation of a germline TERT variant in a patient with juvenile myelomonocytic leukemia.

    Janczar S, Kirschner M, Beier F, et al.

    Pediatric blood & cancer 2022; (69(10)):e29909 doi:10.1002/pbc.29909.

    PMID: 35927969

This page is for informational purposes only and does not constitute medical advice. A specialist and genetic counselor can help interpret your telomere, genetic, blood, and biopsy results.